CO6640328A2 - Composición farmacéutica que comprende drospirenona y kit anticonceptivo - Google Patents

Composición farmacéutica que comprende drospirenona y kit anticonceptivo

Info

Publication number
CO6640328A2
CO6640328A2 CO12235600A CO12235600A CO6640328A2 CO 6640328 A2 CO6640328 A2 CO 6640328A2 CO 12235600 A CO12235600 A CO 12235600A CO 12235600 A CO12235600 A CO 12235600A CO 6640328 A2 CO6640328 A2 CO 6640328A2
Authority
CO
Colombia
Prior art keywords
drospirenone
pharmaceutical composition
contraceptive kit
present
contraceptive
Prior art date
Application number
CO12235600A
Other languages
English (en)
Spanish (es)
Inventor
Philippe Perrin
Jose Velada
Dominique Drouin
Original Assignee
Philippe Perrin
Leon Farma Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6640328(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philippe Perrin, Leon Farma Sa Lab filed Critical Philippe Perrin
Publication of CO6640328A2 publication Critical patent/CO6640328A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO12235600A 2010-06-29 2012-12-28 Composición farmacéutica que comprende drospirenona y kit anticonceptivo CO6640328A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28

Publications (1)

Publication Number Publication Date
CO6640328A2 true CO6640328A2 (es) 2013-03-22

Family

ID=48802149

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12235600A CO6640328A2 (es) 2010-06-29 2012-12-28 Composición farmacéutica que comprende drospirenona y kit anticonceptivo

Country Status (14)

Country Link
KR (1) KR102210982B1 (cg-RX-API-DMAC7.html)
BR (1) BR122019008317A2 (cg-RX-API-DMAC7.html)
CL (1) CL2012003685A1 (cg-RX-API-DMAC7.html)
CO (1) CO6640328A2 (cg-RX-API-DMAC7.html)
DK (1) DK2588114T3 (cg-RX-API-DMAC7.html)
EC (3) ECSP12012359A (cg-RX-API-DMAC7.html)
ES (1) ES2777886T3 (cg-RX-API-DMAC7.html)
GT (3) GT201200336BA (cg-RX-API-DMAC7.html)
HR (1) HRP20200155T1 (cg-RX-API-DMAC7.html)
HU (1) HUE047689T2 (cg-RX-API-DMAC7.html)
LT (2) LT2588114T (cg-RX-API-DMAC7.html)
MX (3) MX364971B (cg-RX-API-DMAC7.html)
PT (1) PT2588114T (cg-RX-API-DMAC7.html)
ZA (1) ZA201209743B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250129555A (ko) 2024-02-22 2025-08-29 단국대학교 천안캠퍼스 산학협력단 드로스피레논을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
LTPA2021523I1 (cg-RX-API-DMAC7.html) 2021-11-10
MX339952B (es) 2016-06-20
KR102210982B1 (ko) 2021-02-02
ES2777886T3 (es) 2020-08-06
MX2012014629A (es) 2013-05-06
HUE047689T2 (hu) 2020-05-28
GT201200336BA (es) 2017-10-23
MX364971B (es) 2019-05-16
KR20190073598A (ko) 2019-06-26
ZA201209743B (en) 2014-03-26
ECSP15032911A (es) 2016-01-29
MX2019004393A (es) 2019-09-09
GT201200336AA (es) 2017-10-23
DK2588114T3 (da) 2020-02-17
PT2588114T (pt) 2020-02-20
LT2588114T (lt) 2020-02-25
ECSP12012359A (es) 2013-03-28
CL2012003685A1 (es) 2013-07-05
GT201200336A (es) 2014-01-14
HRP20200155T1 (hr) 2020-05-01
ECSP15032906A (es) 2016-01-29
BR122019008317A2 (pt) 2020-09-29

Similar Documents

Publication Publication Date Title
AR081670A1 (es) Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
UY32626A (es) Inhibidores de beta-lactamasa
ECSP11011340A (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
CR20110216A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
UY32793A (es) Compuestos inhibidores de los virus flaviviridae, composición farmacéutica que los contiene y sus usos
CO6741203A2 (es) Derivados de biciclo[3,2,1]octilamida y sus usos
MX338535B (es) Inhibidores de ibat para el tratamiento de enfermeades hepaticas.
AR075442A1 (es) Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
CL2013000304A1 (es) Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
MX2015008233A (es) Nuevos derivados de quinolona.
MX2014004871A (es) Composiciones de escoria que comprenden latex y metodos de uso.
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
EP2782583A4 (en) METHOD AND COMPOSITIONS FOR REDUCING AN ALCOHOL TOXICITY
HN2008001521A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR093126A1 (es) Formulaciones de liberacion modificada para oprozomib
HN2011002578A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide.
CR20120548A (es) Comprimido de desintegración por vía oral que contiene acarbosa
CO7111279A2 (es) Composiciones farmacéuticas orales estables de liberación inmediata que contienen prasugrel
CY1115983T1 (el) Συνθεση toy aliskiren
ECSP12012359A (es) Composición farmacéutica que comprende drospirenona y kit anticonceptivo
CR20120109A (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP10010292A (es) Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Legal Events

Date Code Title Description
FC Application refused